Fidelity protocol for the Action Success Knowledge (ASK) trial: A psychosocial intervention administered by speech and language therapists to prevent depression in people with post-stroke aphasia by Carragher, Marcella et al.
Bond University
Research Repository
Fidelity protocol for the Action Success Knowledge (ASK) trial
Carragher, Marcella; Ryan, Brooke; Worrall, Linda; Thomas, Shirley; Rose, Miranda;
Simmons-Mackie, Nina; Khan, Asad; Hoffmann, Tammy C.; Power, Emma; Togher, Leanne;
Kneebone, Ian
Published in:
BMJ Open
DOI:
10.1136/bmjopen-2018-023560
10.1136/bmjopen-2018-023560
Published: 01/05/2019
Document Version:
Publisher's PDF, also known as Version of record
Link to publication in Bond University research repository.
Recommended citation(APA):
Carragher, M., Ryan, B., Worrall, L., Thomas, S., Rose, M., Simmons-Mackie, N., ... Kneebone, I. (2019).
Fidelity protocol for the Action Success Knowledge (ASK) trial: A psychosocial intervention administered by
speech and language therapists to prevent depression in people with post-stroke aphasia. BMJ Open, 9(5),
[e023560]. https://doi.org/10.1136/bmjopen-2018-023560, https://doi.org/10.1136/bmjopen-2018-023560
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
For more information, or if you believe that this document breaches copyright, please contact the Bond University research repository
coordinator.
Download date: 09 Jul 2019
1Carragher M, et al. BMJ Open 2019;9:e023560. doi:10.1136/bmjopen-2018-023560
Open access 
Fidelity protocol for the Action Success 
Knowledge (ASK) trial: a psychosocial 
intervention administered by speech 
and language therapists to prevent 
depression in people with post-
stroke aphasia
Marcella Carragher,  1 Brooke Ryan,2 Linda Worrall,2 Shirley Thomas,3 
Miranda Rose,1 Nina Simmons-Mackie,4 Asad Khan,2 Tammy C Hoffmann,5 
Emma Power,6 Leanne Togher,7 Ian Kneebone6
To cite: Carragher M, Ryan B, 
Worrall L, et al.  Fidelity 
protocol for the Action Success 
Knowledge (ASK) trial: a 
psychosocial intervention 
administered by speech and 
language therapists to prevent 
depression in people with 
post-stroke aphasia. BMJ Open 
2019;9:e023560. doi:10.1136/
bmjopen-2018-023560
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
023560).
Received 24 July 2018
Revised 6 January 2019
Accepted 11 January 2019
For numbered affiliations see 
end of article.
Correspondence to
Dr Marcella Carragher;  
 m. carragher@ latrobe. edu. au
Protocol
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Introduction Treatment fidelity is a complex, multifaceted 
evaluative process which refers to whether a studied 
intervention was delivered as intended. Monitoring and 
enhancing fidelity is one recommendation of the TiDIER 
(Template for Intervention Description and Replication) 
checklist, as fidelity can inform interpretation and 
conclusions drawn about treatment effects. Despite the 
methodological and translational benefits, fidelity strategies 
have been used inconsistently within health behaviour 
intervention studies; in particular, within aphasia intervention 
studies, reporting of fidelity remains relatively rare. This 
paper describes the development of a fidelity protocol for 
the Action Success Knowledge (ASK) study, a current cluster 
randomised trial investigating an early mood intervention for 
people with aphasia (a language disability caused by stroke).
Methods and analysis A novel fidelity protocol and tool 
was developed to monitor and enhance fidelity within the 
two arms (experimental treatment and attention control) 
of the ASK study. The ASK fidelity protocol was developed 
based on the National Institutes of Health Behaviour 
Change Consortium fidelity framework.
Ethics and dissemination The study protocol was 
approved by the Darling Downs Hospital and Health 
Service Human Research Ethics Committee in Queensland, 
Australia under the National Mutual Acceptance scheme 
of multicentre human research projects. Specific ethics 
approval was obtained for those participating sites who 
were not under the National Mutual Agreement at the time 
of application. The monitoring and ongoing conduct of the 
research project is in line with requirements under the 
National Mutual Acceptance. On completion of the trial, 
findings from the fidelity reviews will be disseminated via 
publications and conference presentations.
trial registration number ACTRN12614000979651.
IntroduCtIon   
Treatment fidelity is a complex, multifaceted 
evaluative process. The aim is to increase 
scientific confidence in the findings of 
behavioural intervention studies by moni-
toring and enhancing the reliability and 
validity of the intervention(s) delivered.1 2 
For studies of interventions for health-related 
behaviour change, a high level of treatment 
fidelity is a marker of quality, indicating that 
end users (ie, researchers, clinicians, health-
care providers and patients) can have confi-
dence in the study’s findings.3 Monitoring 
and enhancing treatment fidelity forms part 
of the TiDIER (Template for Intervention 
Description and Replication) recommen-
dations, a consensus reporting checklist 
aimed at enhancing the complete descrip-
tion of interventions.4 Without treatment 
fidelity, conclusions cannot be drawn about 
strengths and limitations of this study
 ► The Action Success Knowledge (ASK) trial’s fideli-
ty protocol is a pragmatic, considered evaluative 
process, based on the National Institutes of Health 
Behaviour Change Consortium.
 ► The fidelity protocol sets out the checks and balanc-
es in place to monitor and enhance fidelity within 
delivery of a complex intervention.
 ► One limitation of the ASK fidelity protocol and check-
list is that it primarily focuses on how the provider 
administers treatment to participants with aphasia, 
as they are the main focus for change.
 ► Treatment receipt and enactment are embedded 
within the design of the ASK intervention (as demon-
strated by the use of accessible aphasia-friendly 
materials, personalised goal-setting and follow-up 
telephone reviews), but they are not directly 
assessed.
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treatment effects, leaving open the possibility for type 
I, type II or type III errors.1 3 5 Within a therapy trial, a 
common component of fidelity monitoring is to evaluate 
and enhance the extent to which the therapy provider 
administers the treatment as planned and how compe-
tently treatment is delivered.6–9 The purpose of this paper 
is to describe the development of a fidelity protocol for 
the Action Success Knowledge (ASK) study, a current 
cluster randomised trial investigating an early mood inter-
vention for people with poststroke aphasia (an acquired 
language and communication disability). The protocol 
for the ASK trial has been published elsewhere.10 Data 
collection is currently ongoing; the results of the fidelity 
monitoring will be reported at the end of data collection, 
as part of the trial results paper.
Despite the methodological and translational bene-
fits, fidelity monitoring has been used inconsistently 
within health behaviour intervention studies,11 and no 
single method has been widely adopted across studies.12 
Assessing treatment fidelity is challenging in the context 
of complex behavioural treatments.13 Such behavioural 
treatments tend to be situated within an interaction 
between the therapy provider and the participant and 
involve a degree of customisation to suit the needs of 
the individual patient.8 14 Interpersonal interaction is an 
important contributing factor in delivering a high-quality 
treatment but creates challenges in training and moni-
toring treatment administration.13 The need for individual 
tailoring of the treatment to meet the needs of the patient 
creates high potential for variation in how the treatment 
is administered, particularly when the treatment is admin-
istered by different providers and across research sites.15 
In response to these challenges, a comprehensive frame-
work was developed by a panel of experts who formed 
the Treatment Fidelity Workshop as part of the National 
Institutes of Health Behaviour Change Consortium (NIH 
BCC).1–3 The NIH BCC framework expands on previous 
concepts of treatment fidelity to provide five domains of 
guidance for researchers within the broad field of health 
behaviour treatment (table 1).
brief background of fidelity monitoring in aphasia treatment 
studies
A review of 149 aphasia treatment studies published 
between 2002 and 2011 found only 14% of aphasia 
therapy studies reported treatment fidelity.5 A more 
recent review16 of 42 aphasia randomised controlled 
trials (RCTs) published since 2012 found that 21% 
reported on treatment fidelity processes and one 
article addressed all receommended treatment fidelity 
components.17 
Given the relative scarcity of fidelity monitoring 
inaphasia treatment studies and in the related fields of 
psychological treatment,5 18 it was necessary to develop a 
novel fidelity protocol and tool for the ASK study. The 
NIH BCC fidelity framework was used to inform and 
develop a fidelity protocol for the ASK study (table 1).
the AsK trial
The ASK study is an ongoing Australian-based multi-
centre, cluster-randomised controlled trial with a target 
recruitment n of 344, funded by the National Health and 
Medical Research Council (for more information, see 
the trial protocol10). The experimental treatment targets 
psychosocial well-being and was developed in recogni-
tion of the high incidence of depression in this popula-
tion, estimated to be 62%–70% and higher than in the 
general stroke population without aphasia.19 The nature 
of aphasia makes it difficult for individuals to access 
usual care psychological treatments, which are typically 
‘talking therapies’.20 Speech pathologists are well-placed 
to provide treatment, but they report feeling uncertain 
about how to do this.21 The ASK trial trains speech pathol-
ogists to deliver either a psychosocial treatment (experi-
mental treatment) or an information-focused treatment 
relating to secondary stroke prevention (attention control 
treatment).
theoretical underpinnings of the AsK interventions
The ASK experimental treatment draws on previous 
research which explored what factors influence living 
successfully with chronic aphasia.22 23 Themes identified 
as being key to living successfully with aphasia included: 
engaging in meaningful activities; having sufficient social 
support and positive adaptive strategies. These themes 
served as a search strategy to identify relevant psychosocial 
interventions that could be adapted for the population of 
people with aphasia. That is, the psychosocial intervention 
literature was explored to identify which interventions 
mapped onto the themes previously identified as influen-
tial in living successfully with aphasia. Those psychosocial 
interventions with the highest available evidence were 
incorporated into modules within the ASK experimental 
intervention. Thus, the ASK experimental intervention is 
underpinned by theories of positive psychology24 social 
problem-solving,25 adult learning26 and the life participa-
tion approach to aphasia.27 28
The attention control treatment is a secondary stroke 
prevention information programme that draws on 
previous research with patients with stroke.29 30 The inter-
vention is underpinned by theories of adult learning,31 
the health belief model32 33 and self-efficacy theory.32 This 
specific intervention was chosen as an attention control 
as it can be provided in a similar dosage and format to 
the ASK intervention. Furthermore, the content of a 
secondary stroke prevention information programme is 
relevant to all patients with stroke. The materials were 
adapted in line with aphasia-friendly formatting prin-
ciples.34 The provision of secondary stroke prevention 
information has had no known demonstrated effect on 
the primary outcomes used in the ASK trial.
A central component of both the experimental 
and attention control interventions are the specific 
approaches of Supported Conversation for Adults with 
Aphasia (SCA).35 SCA acknowledges the ‘success’ of a 
conversation is not wholly dependent on the severity 
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Table 1 Comprehensive fidelity framework developed by the NIH BCC (synthesised from 1, 2, 3), with the ASK fidelity 
protocol mapped alongside these recommendations
Domain Rationale NIH BCC recommendations Fidelity protocol within the ASK trial
Study design Ensures the study adequately tests its 
hypotheses
Specify the theoretical model underlying the 
treatments and define the ‘active ingredients’ of the 
treatment
Theoretical underpinnings identified and ‘active 
ingredients’ proposed
Conduct a pilot study to improve the treatment’s 
acceptability, feasibility and effectiveness
Pilot study conducted37
Specify the treatment dose within and 
across conditions and ensure this is delivered
Treatment dose set a priori and non-adherence is 
recorded as a protocol deviation
Plan how to monitor adherence to the protocol for 
therapy providers
Fidelity plan developed, as reported in the current 
study
Plan how to record protocol deviations Training provided to trial staff to identify protocol 
deviations, which are reported and recorded in 
REDCap
Describe the treatment(s) in a standardised manual Each treatment described in a standardised manual
Plan how to manage setbacks, eg, attrition of 
providers
All sites/clusters receive initial face-to-face training. 
Subsequent training (eg, for new staff or booster 
training) is delivered via video conference
Training Well-trained providers are more likely to 
follow the protocol and show increased 
competency
Therapy providers should a) have similar 
qualifications and experience, and b) ‘buy in’ to 
key aspects of the study (theory, randomisation, 
intervention)
All therapy providers are qualified speech 
pathologists
Providers’ ‘buy in’ is not assessed
Standardise training using the same trainers and 
materials but accommodate differences in learning 
styles
Training is centralised (provided by the trial manager) 
and standardised
All training is provided by one of two trainers (trial 
managers)
Measure skill acquisition and knowledge following 
training
Not assessed in the current protocol
Develop a training plan to ensure providers maintain 
skills, eg, ongoing coaching and feedback, booster 
training sessions
Booster training is offered for providers to refresh 
their knowledge. This training can be accessed at any 
time at the request of the therapy provider
Train the providers in study design and the 
methodology of the study, including preventing 
contamination across treatment arms
Training includes study design and methodology as 
well as role-specific information and skills
Contamination across arms is reduced by the study 
design, ie, clusters of sites were randomised to one 
of two treatment arms
Treatment delivery Ensures that providers deliver only the 
target treatment (treatment differentiation); 
maintain the required skills set (treatment 
competence) and administer the treatment 
as intended (treatment adherence)
Assessment of fidelity of delivery will a) drive 
supervision to improve/maintain provider 
skills and b) can be used in analytical 
models to investigate the relationship 
between treatment fidelity and outcome
Develop the willingness and confidence of providers 
to report protocol deviations
This is not directly assessed within the ASK fidelity 
monitoring
Monitor non-specific treatment effects, eg, perceived 
differences in providers’ warmth and credibility, 
participant expectations
Fidelity criteria requires therapy providers 
to demonstrate engagement, rapport and warmth, in 
line with their familiarity with the participant
Reduce differences within the same treatment, and 
maximise differences between treatments
Audio-video recordings of interventions are rated by 
the fidelity monitor for presence/absence of essential 
and desirable behaviours
Following review of the video-recorded intervention 
session, the fidelity monitor provides written and 
verbal feedback and coaching to therapy providers
Ensure adherence to the treatment protocol including 
treatment content and prescribed dose
Therapy providers receive the fidelity criteria prior to 
administering their first session
Booster training offered
Reduce the risk of contamination between 
treatments
Therapy providers are trained in one trial intervention 
only, to reduce the risk of contamination
Enhance adherence to the treatment protocol by 
audio or video recording treatment sessions
All treatment sessions are video recorded and a 
selection are reviewed by the fidelity monitor
Treatment receipt Investigates whether the participant 
understood the treatment and can 
demonstrate knowledge of or application of 
the skills taught in the treatment
Ensure participants understand the information 
provided in the treatment
This is not directly assessed within the ASK fidelity 
monitoring. However, both treatments are delivered 
by qualified speech pathologists who should have 
skills in supporting people with aphasia to get 
their message in (ie, comprehension) and get their 
message out (eg, ask questions, reflect, explain)
Ensure participants are able to apply the cognitive 
and behavioural skills taught in the treatment
This is not directly assessed within the ASK fidelity 
monitoring
Build in strategies to improve performance of skills The fidelity monitor provides specific, tailored 
feedback to the therapy provider on how to target 
behaviour change more explicitly. However, the 
current protocol does not directly assess participants’ 
performance of skills
Continued
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or type of individual’s aphasia; rather, the behaviours of 
the communication partner can influence the success 
of the conversation. As such, SCA sets out specific strat-
egies for communication partners (such as family and 
health professionals) to implement in conversation with 
the individual with aphasia. These strategies are imple-
mented by those around the individual with aphasia 
to support message in (understanding), message out 
(expressing a thought or opinion) and checking that the 
family member or health professional understood what 
the individual with aphasia intended (clarification).
the need to develop a specific fidelity protocol for the AsK 
study
In usual clinical care, speech pathologists do not typically 
lead administration of either of these treatments adding 
to the importance of monitoring fidelity within the ASK 
trial. Fidelity criteria were developed for both the exper-
imental and the attention control treatments, and the 
same level of monitoring and feedback occurs for both 
arms. The rationale for each aspect of the ASK fidelity 
protocol is described below. The study design and training 
components of the fidelity protocol are monitored sepa-
rately to the treatment fidelity of sessions delivered by 
therapy procedures. Criteria for monitoring the fidelity 
of each treatment session were developed to determine 
whether treatment fidelity was achieved by each provider, 
and across participants (tables 2 and 3).
Within the current paper, Section 1 will describe the 
fidelity processes within the ASK trial and how these 
processes map onto the NIH BCC framework. The fidelity 
criteria used to monitor therapy delivery for both the 
experimental and attention control arms are included 
(tables 2 and 3). Section 2 will focus specifically on 
fidelity monitoring of therapy delivery. Here, we describe 
the procedure for reviewing intervention sessions, such 
as the procedure for therapy providers to submit audio-
video recordings. Figure 1 provides a schematic of this 
procedure.
sECtIon 1
overview of the AsK treatments
The ASK treatments consist of weekly face-to-face sessions 
(minimum of 3, maximum of 8 sessions) followed by 
monthly telephone reviews until the participant reaches 
12 months poststroke. The treatment is delivered by a 
speech pathologist who has been trained in the trial 
protocol and the study treatment. The first face-to-face 
treatment session focuses on goal-setting, when the 
therapy provider works with the participant with aphasia 
and their family member to generate relevant goals. 
Goal development is supported by the Goal Attainment 
Scale36 and written in a way that is accessible for individ-
uals with aphasia. After the goal-setting session, the ther-
apist is able to use the goals to a) tailor the content of 
the treatment modules to the participants’ specific needs 
and b) help the participants to reflect on any perceived 
changes during the course of the treatment. Within the 
experimental treatment, homework tasks are agreed at 
the end of each session, with the aim of supporting the 
participant to enact the strategies outside of the treat-
ment sessions. Homework tasks are not prescribed in the 
attention control intervention. The content of the inter-
vention modules are subject to ongoing investigation 
within the trial; to reduce the risk of unblinding asses-
sors and/or participants the content of treatment will not 
be discussed in detail in this paper. For further details 
regarding the protocol of the trial, see Worrall et al.10
development of fidelity processes within the AsK trial
Study design
The experimental ASK treatment was piloted in a Phase 
I feasibility study of n=9 participants.37 This development 
work led to production of a standardised manual for the 
experimental treatment detailing the theoretical basis of 
the treatment; supporting information for each module 
and plans to monitor treatment fidelity, protocol devi-
ations, data management and safety. Clusters (health 
service districts) provide one trial treatment to minimise 
potential for contamination between the treatments. 
Further information can be found in the protocol paper.10
Treatment dose was specified a priori including the 
length of each treatment session, the number of face-
to-face sessions and telephone reviews, and maximum 
duration of the treatment time. Participants across the 
experimental and attention control arms receive the 
same dose and frequency of treatment. A minimum and 
maximum treatment dose was set to allow for individual 
preferences of the participants with aphasia (minimum of 
3, maximum of 8 face-to-face weekly sessions). Following 
face-to-face treatment, participants receive monthly tele-
phone reviews. Participants are recruited and complete 
baseline assessment within 6 months poststroke, and treat-
ment ceases at the participant’s 12-month anniversary of 
their stroke. For all sessions (face-to-face and telephone), 
treatment dose within and between groups is monitored 
Domain Rationale NIH BCC recommendations Fidelity protocol within the ASK trial
Enactment Monitors and supports participants to use 
treatment-related skills and strategies in 
real-life situations
Acknowledges the difference between 
what is taught (treatment delivery), what is 
learnt (treatment receipt) and what is used 
(enactment)
Assess use and performance of cognitive and 
behavioural skills in an appropriate setting outside of 
the treatment
This is not directly assessed within the ASK fidelity 
monitoring. However, enactment is supported 
through goal-setting and ongoing reflect on 
achievement of goals. Furthermore, an essential 
criteria for the experimental intervention relates to 
setting homework tasks after each session and 
reporting on this in the following session
Table 1 Continued 
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via data records submitted by therapy providers. Any 
changes in dose are recorded as a ‘protocol deviation’, 
for example, a missed session due to participant illness. 
While family members are also recruited as participants 
and are invited to attend the treatment sessions, the treat-
ment dose relates specifically to the participants with 
aphasia, as they are the primary targets of the treatments.
Provider training
Standardised manuals and materials were developed for 
each role within the trial, that is, blinded assessor, recruiter 
and therapy provider. All roles are carried out by speech 
pathologists who have been trained by members of the 
trial management team, who are qualified speech pathol-
ogists. The assessor manual emphasises the theoretical 
underpinnings of each of the assessments, instructions on 
administration, skills required and data management and 
safety. Blinded assessors are usually contracted as casual 
employees nominated by the principal investigator at 
each site as suitable for this role.
Within both arms, the treatment manuals contain 
information on the theoretical underpinnings of the 
treatment as well as information on each module, data 
management and safety. Therapy is provided either by a 
private therapist employed as a casual employee of the 
trial, or by speech pathology staff at the participating clus-
ters. In the case of the latter, suitable therapists are iden-
tified as those whose usual duties bring them into contact 
with patients with aphasia for screening, recruitment and 
administration of the study treatment.
Table 2 Fidelity criteria for treatment delivery within the goal-setting session for the experimental treatment and the attention 
control treatment
Active ingredient Behaviour
Fidelity 
component
Experimental 
treatment
Attention control 
treatment
Principles of supported 
conversation
Used appropriate level of communication strategies 
to support the person with aphasia’s (PWA) receptive 
language skills
For example, adapted resources, writing, gesture, 
drawing, repetition
Competence Essential criteria Essential criteria
Principles of supported 
conversation
Used appropriate level of communication strategies 
to support the PWA’s expressive language skills
For example, suggested using drawing, writing, 
pointing, gesture, verification
Competence Essential criteria Essential criteria
Collaborative learning
Person-centred 
approach
Did not use preset goals without discussion with the 
PWA (and family member)
Content Essential criteria Essential criteria
Person-
centred approach
Goal-oriented approach
The therapist delivered only the target treatment as 
described in the manual and in training sessions
Content Essential criteria Essential criteria
Person-
centred approach
Goal-oriented approach
Gave a rationale for goal-setting Content Essential criteria Essential criteria
Person-
centred approach
Goal-oriented approach
Collaborative learning
Problem solved with the PWA (and family member) to 
set personally relevant goals
For example, guided discussion about the goals and 
options within the treatment; explained why specific 
goals do not fall under the study treatment and how 
to address these concerns; helped PWA (and family 
member) gain new understanding of problems/goals; 
helped PWA (and family member) to prioritise goals
Content Essential criteria Essential criteria
Collaborative learning Demonstrated an appropriate level of engagement, 
rapport and warmth, in line with their familiarity with 
the PWA (and family member)
For example, warm tone of voice; appropriate use of 
humour; avoidance of criticism; encouragement of 
communication attempts
Competence Desirable criteria Desirable criteria
Collaborative learning Evidence of therapeutic alliance
For example, checked that the goals reflect the PWA’s 
(and family member’s) needs; avoided dominating the 
discussion; used active listening; adapted approach 
to engage the PWA (and family member)
Competence Desirable criteria Desirable criteria
Total score (max 8, min 6.4)
Essential behaviours score (min 6)
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Table 3 Fidelity criteria for treatment delivery within the treatment modules
Active ingredient Behaviour
Fidelity 
component
Experimental 
treatment
Attention control 
treatment
Principles of 
supported 
conversation
Used appropriate level of communication 
strategies to support the person with aphasia’s 
(PWA) receptive language skills
For example, adapted resources, writing, gesture, 
drawing, repetition
Competence Essential criteria Essential criteria
Principles of 
supported 
conversation
Used appropriate level of communication 
strategies to support the PWA’s expressive 
language skills
For example, suggested using drawing, writing, 
pointing, gesture, verification
Competence Essential criteria Essential criteria
Behaviour change
Person-centred
The therapist delivered only the target treatment as 
described in the manual and in training sessions
For example, spent the majority of the session 
discussing topics related to the study treatment; 
for queries/discussions not related to the study 
treatment, therapist dealt appropriately or sign-
posted to an appropriate source of information or 
advice
Content Essential criteria Essential criteria
Collaborative learning Explained the rationale for the module
For example, how the treatment module relates to 
the participant’s (and family member’s) goals
Content Desirable criteria Desirable criteria
Collaborative learning Demonstrated an appropriate level of engagement, 
rapport and warmth, in line with their familiarity 
with the PWA (and family member)
For example, warm tone of voice; appropriate use 
of humour; avoidance of criticism; encouragement 
of communication attempts; identified what 
information the PWA (and family member) already 
had access to in relation to the study treatment and 
the gaps in information/understanding
Competence Desirable criteria Desirable criteria
Collaborative learning Evidence of therapeutic alliance
For example, seeks agreement; avoid dominating 
the discussion; active listening; adapts approach to 
engage the PWA (and family member)
Competence Desirable criteria Desirable criteria
Behaviour change Reviewed homework from the previous module 
and explored reasons for non-completion of 
homework—experimental treatment only
Content Desirable criteria Not targeted
Behaviour change
Person-centred
Targeted behavioural change—experimental 
treatment only
For example, asked questions to gain a better 
understanding of the PWA (and family member); 
asked questions to prompt the PWA (and family 
member) to explore the topic or to make it 
personally relevant to them; used the written 
materials as a platform to generate further 
discussion; discussed challenges to achieving the 
goal for the specific module and worked with the 
participant to problem-solve; prompted the PWA 
(and family member) to keep a written note of any 
activities they wanted to action as ‘homework’
Competence Essential criteria Not targeted
Behaviour change
Person-centred 
approach
Effectively engaged the PWA (and family member) 
in the practical activities—experimental treatment 
only
For example, gave accurate feedback on practical 
activities; agreed an appropriate homework
Competence Desirable criteria Not targeted
Experimental 
treatment
Total score (max 9, min 7.2)
Essential behaviours score (min 4)
Attention control 
treatment
Total score (max 6, min 4.8)
Essential behaviours score (min 3)
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Training for therapy providers across the trial arms 
is standardised, ensuring that all providers have access 
to the same content and amount of training. Training 
is carried out in person or via video conferencing with 
small groups of therapists, for the duration of 3 hours (for 
assessors or recruiters) or 6 hours (for therapy providers). 
Online refresher/booster training is available to all staff; 
this can be requested by the staff member at any time. 
Typically, staff access booster training following a period 
of leave. For therapy providers, the aim of the training 
programme is to ensure that staff understand the trial 
procedures, the rationale and theory behind the treat-
ment, and how to tailor the treatment to suit the needs 
of an individual participant while not deviating from the 
essential components of the treatment.
Treatment delivery
Fidelity of treatment delivery is defined as the extent to 
which the therapist administers the treatment as planned 
and the competency with which the treatment is deliv-
ered.6–9 According to Bellg et al,2 assessment of treatment 
delivery includes monitoring and improving how therapy 
providers a) deliver only the target treatment (differen-
tiation); b) acquire and maintain the required skills set 
(competency) and c) deliver the intended treatment 
components (adherence). ASK therapy providers receive 
a treatment manual which details the essential compo-
nents of goal-setting as well as each of the treatment 
modules. Therapy providers are encouraged to tailor 
treatment to the individual needs of the participant, for 
example, through setting personalised, meaningful goals. 
In the experimental treatment, this tailoring is essential 
in order to encourage and support the participant to 
make changes in their behaviour, for example, shifting 
from potentially negative coping strategies to positive 
strategies. In the attention control treatment, tailoring 
ensures participants receive information that is relevant 
to them and at a pace that is acceptable.
Fidelity of treatment delivery is monitored using video 
recording of treatment sessions; recording is considered 
the ‘gold standard’ for monitoring treatment fidelity.2 All 
assessment and treatment sessions within the ASK trial 
are video recorded. Each therapy provider submits the 
Figure 1 Fidelity assessment of the Action Success Knowledge trial experimental and attention control treatments.
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audio-video recording of his/her first goal-setting session 
and first intervention module for assessment by the ASK 
fidelity monitor. This ensures that any deviation from the 
treatment is identified early by the fidelity monitor and 
steps taken to improve adherence to the target treatment. 
Providers’ behaviours are assessed in relation to content 
components and competency skills; see the ‘Procedure for 
monitoring and enhancing treatment delivery’ section. Due 
to their familiarity with the interventions and as they are 
unblinded as to the randomisation allocation of each 
site, the fidelity monitor role is carried out by one of two 
trial managers. As noted, the trial managers also deliv-
ered training to blinded assessors, recruiters and therapy 
providers within the trial.
Care is taken to engage the providers in the fidelity 
process and to be sensitive to any potential nega-
tive emotions they may feel when receiving feedback 
on their delivery of the study intervention. During 
the initial training session, the rationale for video 
recording treatment sessions is explained along with 
an outline of the process of fidelity checking including 
who will watch the video, how it will be assessed and 
what will happen if criteria are not met. This discus-
sion highlights the importance of mutual respect, 
transparency and building trust. Therapy providers 
give their written consent to be video recorded. Before 
administering their first treatment sessions, therapy 
providers receive the treatment delivery fidelity 
criteria. This serves to further emphasise the essential 
components of the treatment and aims to reduce any 
provider anxiety relating to what the integrity monitor 
is assessing in the video recordings of treatment.
Treatment receipt
This category of fidelity focuses on whether the treat-
ment was accurately ‘received’ by the participant (p. 8, 
3). Borrelli points out that even if a treatment has been 
well-designed and competently delivered, the treat-
ment will be ineffective if the participant is unable to 
understand or use the new skills. The target popula-
tion of the ASK trial is people with aphasia and their 
family members. Aphasia can affect understanding, 
both through auditory and written modalities. Treat-
ment receipt was not directly assessed; rather, it was 
embedded in the development of the treatment and 
materials, as well as provider training and treatment 
delivery. A number of steps were taken to support 
participants’ comprehension: the treatment mate-
rials were developed based on aphasia-friendly guide-
lines including simplified language, larger font, key 
words in bold, use of photographs/diagrams/pictures 
to support the written text and blank space.38 39 The 
treatment materials were developed by the research 
team before any participant commenced treatment. 
Essential criteria in the treatment fidelity checklist 
(tables 2 and 3) relate to the provider using tech-
niques to support the participant with aphasia to 
understand (message in) and techniques to support 
the participant to ask questions, or express their 
thoughts or feelings, or to demonstrate their inter-
pretation of the conversation (message out). These 
techniques draw on an evidence base of supported 
conversation,35 and are essential to ensure that the 
treatment is being delivered in an accessible way to 
participants with aphasia.
Enactment of treatment skills
While Bellg et al2 acknowledge that treatment enactment 
is difficult both to conceptualise and to implement, they 
argue there is an important distinction between ‘what 
is taught (treatment delivery), what is learnt (treatment 
receipt) and what is actually used (enactment)’ (p. 450). 
Within the ASK study, enactment of treatment skills is not 
directly assessed or monitored but is supported in various 
ways.
a. For both the experimental and attention control in-
terventions, the therapy provider and participants 
work together to generate person-specific, meaningful 
goals. Regular goal review throughout the interven-
tion means that participants can report on how they 
are progressing and/or update their goals as needed. 
Goal-setting is assessed by the fidelity monitor and 
feedback given regarding the appropriateness of goals; 
goal achievement is not assessed within the fidelity 
monitoring process.
b. For both the experimental and attention control in-
terventions, enactment is supported via follow-up 
telephone sessions for both arms. After attending face-
to-face sessions with the therapy provider, participants 
receive monthly telephone calls from the therapy pro-
vider until the 12-month anniversary of their stroke. 
The purpose of these calls is to reflect on progress re-
lated to the participant’s goals, check if the participant 
requires more information or discussion in relation to 
these and to explore any obstacles to enacting the skills 
taught in treatment. The telephone sessions are audio 
recorded and clinicians submit data on the nature of 
the discussion and length of the call.
c. For the experimental intervention only, it is an es-
sential fidelity criterion that therapy providers set 
homework with each participant. The homework task 
is set at the nd of each session, reflecting the discus-
sion that took place in the session. The homework 
task builds on the most recent therapy session and/or 
generates opportunities for the participant to practise 
a skill outside of the clinic. In the following session, 
the therapy provider reviews the homework with the 
participant. Reasons for non-completion of home-
work are explored, as these can indicate a lack of un-
derstanding or obstacles to implementing the learnt 
skills. The therapy provider’s behaviours (ie, setting 
and reviewing homework tasks) are monitored within 
the fidelity review; the participant’s completion of the 
tasks as directed is not directly assessed in the fidelity 
process.
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sECtIon 2
Procedure for monitoring and enhancing treatment delivery
All assessment and face-to-face treatment sessions are 
video recorded. Each therapy provider submits his/her 
first goal-setting session and first module for assessment 
by the ASK fidelity monitor. Dependent on resources 
within the trial, later sessions are selected at random for 
fidelity checking to ensure skills have been maintained. 
In particular, assessing the first goal-setting session and 
the first module ensures that any deviation from the treat-
ment is identified early by the fidelity monitor and steps 
are taken to improve adherence to the target treatment. 
The fidelity monitor watches 100% of the recordings of 
the goal-setting and first modules; this allows the fidelity 
monitor to get a broad sense of the session, rather than 
simply focusing on the frequency of specific behaviours.
Providers’ behaviours are assessed in relation to content 
components and competency skills, and given a score 
based on whether these behaviours were evident in the 
recording (see table 2 for the fidelity criteria relating to 
the goal-setting session, and table 3 for criteria relating 
to the intervention modules). Once fidelity assessment is 
complete, the fidelity monitor provides written and verbal 
feedback to the therapy provider regarding whether they 
met fidelity criteria and on specific aspects of the sessions. 
If fidelity criteria are met, the therapy provider continues 
to video record all subsequent treatment sessions. If the 
therapy provider does not meet fidelity criteria for the first 
goal-setting or module sessions, he/she is provided with 
written and verbal feedback and coaching. Subsequently, 
the therapy provider is required to submit his/her next 
session to ensure that the necessary changes have been 
incorporated. This cycle of submitting a video recording 
and receiving feedback and coaching continues until the 
therapy provider meets the fidelity criteria.
development of a tool to assess treatment delivery fidelity 
within the AsK study
The treatment fidelity criteria were developed from the 
proposed active ingredients of each treatment module. 
These criteria reflect the content components and the 
competency skills necessary to deliver the target treatment 
(see table 2 for fidelity criteria relating to the goal-setting 
session; see table 3 for fidelity criteria relating to the treat-
ment modules). Inter-rater reliability is currently being 
investigated as the trial continues to collect data.
Adherence to content components
The key content components of the treatment were 
identified for each module (goal-setting module and the 
therapy modules) based on the underlying theory and 
evidence.
Adherence to competency skills
Competency skills were defined as the communication 
strategies used by the provider to support the partic-
ipant with aphasia to understand the information 
and to express their thoughts, feelings and questions. 
Identification of these skills was informed by the extensive 
literature on supported communication, that is, there is 
strong evidence to suggest the skill of the communication 
partner can have a substantial impact on the communica-
tion ability of the person with aphasia.40 41
Overall marker of quality of the treatment session
All behaviours (content and competency) are categorised 
as either ‘essential’ or ‘desirable’. To demonstrate fidelity 
to the intervention protocol, therapy providers must 
demonstrate 100% of all essential behaviours. Addition-
ally, providers must also demonstrate a minimum number 
of desirable behaviours (ie, considered high quality but 
not essential). Feedback on all behaviours is provided to 
the therapy providers. Evaluation of adherence to treat-
ment content and competency components involves 
scoring occurrences of behaviours; a binary system of 
‘present’ (1 point) or ‘absent’ (0 points) is applied and 
the scores counted. Scores for essential and desirable 
behaviours are combined to give a total maximum score 
for each session; a higher score is interpreted as a marker 
of quality of the treatment session. The threshold is set 
at 100% adherence to essential criteria and an overall 
minimum score of 80% adherence, that is, therapists 
need to demonstrate at least 80% fidelity to the protocol 
to be considered adherent. A score below the minimum 
results in the conclusion that the therapist has not met 
the treatment fidelity criteria for that session.
ConClusIon
Within health-related behavioural treatment studies, it 
is crucial that treatment fidelity is monitored, enhanced 
and reported in order to increase the power to detect 
treatment effects and to increase confidence in the 
study’s findings. Monitoring treatment fidelity is still rela-
tively rare in the field of aphasia treatment studies, with 
a previous review indicating that 14% of aphasia studies 
reported fidelity5, with a more recent review indicating 
that 21% of aphasia RCTs reported fidelity. The fidelity 
protocol and checklist developed within the ASK trial 
provides a useful template for other aphasia and psycho-
social treatment studies. One limitation of the ASK 
fidelity protocol and checklist is that it primarily focuses 
on how the provider administers treatment to partici-
pants with aphasia, as they are the main focus for change. 
While family members are recruited as participants 
and attend intervention sessions, their participation is 
not included in the current fidelity protocol. Yet, their 
support is likely to be influential in how the individuals 
with aphasia receive the treatment and embed the inter-
vention into everyday life. Future studies of intervention 
involving participants with aphasia and family members 
could consider adding specific fidelity criteria that relates 
to the family member. A further limitation is that, while 
treatment receipt and enactment are embedded within 
the design of the ASK intervention (ie, accessible apha-
sia-friendly materials; personalised goal-setting; follow-up 
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telephone reviews), there is no direct assessment of 
treatment receipt or enactment. In particular, treatment 
enactment is challenging to directly assess and may rely 
on self-report from study participants. Future aphasia 
studies could directly assess treatment receipt and enact-
ment, for example, review whether participants felt they 
had achieved their goals or collect participant self-reports 
on whether the strategies learnt in therapy had become 
embedded into their daily life.
PAtIEnt/ And/or PublIC InvolvEMEnt
Patients and/or public were not involved in the develop-
ment of the ASK fidelity tool.
EthICs And dIssEMInAtIon
The monitoring and ongoing conduct of the research 
project is in line with requirements under the National 
Mutual Acceptance with the submission of progress 
reports, safety and/or adverse event reports and amend-
ments. On completion of the trial, findings from the 
study and from the fidelity reviews will be disseminated 
via publications and conference presentations.
Author affiliations
1School of Allied Health, Human Services and Sport, La Trobe University—
Melbourne Campus, Melbourne, Victoria, Australia
2School of Health and Rehabilitation Sciences, The University of Queensland, St 
Lucia, Queensland, Australia
3Division of Rehabilitation and Ageing, University of Nottingham, Nottingham, UK
4Department of Health and Human Sciences, Southeastern Louisiana University, 
Hammond, Louisiana, USA
5Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, 
Queensland, Australia
6Graduate School of Health, University of Technology Sydney, Sydney, New South 
Wales, Australia
7Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, 
Australia
Contributors LW is the chief investigator for the study and assembled the 
team. All authors contributed to study design. IK oversaw the development of the 
fidelity protocol. As trial managers for this study, BR and MC led staff training and 
monitored videos submitted for fidelity review. MC wrote the fidelity protocol with 
input from IK, BR, ST, LW, NS-M, MR, LT and TCH. MC wrote the draft manuscript; all 
authors (BR, LW, ST, MR, NS-M, AK, TH, EP, LT, IK) contributed to manuscript revision 
and approved the final manuscript for submission.
Funding This research was funded by a grant from the National Health and 
Medical Research Council Project from 2014 to 2018 (APP1060673).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval The study protocol was approved by the Darling Downs Hospital 
and Health Service Human Research Ethics Committee (HREC) in Queensland, 
Australia under the National Mutual Acceptance scheme of multicentre human 
research projects conducted in publicly funded health services. Based on this 
approval, expedited approval for the study was granted by the University of 
Queensland. Ethics approval was also obtained for participating sites not approved 
under the National Mutual Agreement scheme at the time of application. 
Provenance and peer review Not commissioned; externally peer reviewed.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
rEFErEnCEs
 1. Borrelli B, Sepinwall D, Ernst D, et al. A new tool to assess treatment 
fidelity and evaluation of treatment fidelity across 10 years of health 
behavior research. J Consult Clin Psychol 2005;73:852–60.
 2. Bellg AJ, Borrelli B, Resnick B, et al. Enhancing treatment 
fidelity in health behavior change studies: best practices and 
recommendations from the NIH Behavior Change Consortium. Health 
Psychol 2004;23:443–51.
 3. Borrelli B. The assessment, monitoring, and enhancement of 
treatment fidelity in public health clinical trials. J Public Health Dent 
2011;71(s1):S52–S63.
 4. Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of 
interventions: template for intervention description and replication 
(TIDieR) checklist and guide. BMJ 2014;348:g1687.
 5. Hinckley JJ, Douglas NF. Treatment fidelity: its importance and 
reported frequency in aphasia treatment studies. Am J Speech Lang 
Pathol 2013;22:S279–S284.
 6. Moncher FJ, Prinz RJ. Treatment fidelity in outcome studies. Clin 
Psychol Rev 1991;11:247–66.
 7. Perepletchikova F, Kazdin AE. Treatment integrity and therapeutic 
change: issues and research recommendations. Clinical Psychology: 
Science and Practice 2005;12:365–83.
 8. Santacroce SJ, Maccarelli LM, Grey M. Intervention fidelity. Nurs Res 
2004;53:63–6.
 9. Stein KF, Sargent JT, Rafaels N. Intervention research: establishing 
fidelity of the independent variable in nursing clinical trials. Nurs Res 
2007;56:54–62.
 10. Worrall L, Ryan B, Hudson K, et al. Reducing the psychosocial 
impact of aphasia on mood and quality of life in people with aphasia 
and the impact of caregiving in family members through the Aphasia 
Action Success Knowledge (Aphasia ASK) program: study protocol 
for a randomized controlled trial. Trials 2016;17:1–7.
 11. Walton H, Spector A, Tombor I, et al. Measures of fidelity of delivery 
of, and engagement with, complex, face-to-face health behaviour 
change interventions: A systematic review of measure quality. Br J 
Health Psychol 2017;22:872–903.
 12. Thomas SA, Russell C, Seed R, et al. An evaluation of treatment 
integrity in a randomized trial of behavioural therapy for low mood in 
stroke patients with aphasia. Clin Rehabil 2013;27:1097–106.
 13. Song MK, Happ MB, Sandelowski M. Development of a tool to 
assess fidelity to a psycho-educational intervention. J Adv Nurs 
2010;66:673–82.
 14. Carroll KM, Nich C, Sifry RL, et al. A general system for evaluating 
therapist adherence and competence in psychotherapy research in 
the addictions. Drug Alcohol Depend 2000;57:225–38.
 15. Casey AF, Quenneville-Himbeault G, Normore A, et al. A therapeutic 
skating intervention for children with autism spectrum disorder. 
Pediatr Phys Ther 2015;27:170–7.
 16. Brogan E, Ciccone N, Godecke E. Treatment fidelity in 
aphasia randomised controlled trials. Aphasiology 2019. doi: 
10.1080/02687038.2019.1576442.
 17. Marshall J, Booth T, Devane N, et al. Evaluating the benefits of 
aphasia intervention delivered in virtual reality: results of a quasi-
randomised study. PLoS One 2016;11:e0160381.
 18. Gallagher M, McLeod HJ, McMillan TM. A systematic review of 
recommended modifications of CBT for people with cognitive 
impairments following brain injury. Neuropsychol Rehabil 
2019;29:1–21.
 19. Kauhanen ML, Korpelainen JT, Hiltunen P, et al. Aphasia, depression, 
and non-verbal cognitive impairment in ischaemic stroke. 
Cerebrovasc Dis 2000;10:455–61.
 20. Baker C, Worrall L, Rose M, et al. A systematic review of 
rehabilitation interventions to prevent and treat depression in post-
stroke aphasia. Disabil Rehabil 2018;40:1870–92.
 21. Sekhon JK, Douglas J, Rose ML. Current Australian speech-
language pathology practice in addressing psychological well-
being in people with aphasia after stroke. Int J Speech Lang Pathol 
2015;17:252–62.
 22. Brown K, Worrall L, Davidson B, et al. Snapshots of success: An 
insider perspective on living successfully with aphasia. Aphasiology 
2010;24:1267–95.
 23. Grohn B, Worrall L, Simmons-Mackie N, et al. Living successfully 
with aphasia during the first year post-stroke: A longitudinal 
qualitative study. Aphasiology 2014;28:1405–25.
 24. Seligman ME, Steen TA, Park N, et al. Positive psychology progress: 
empirical validation of interventions. Am Psychol 2005;60:410–21.
 o
n
 10 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023560 on 5 May 2019. Downloaded from 
11Carragher M, et al. BMJ Open 2019;9:e023560. doi:10.1136/bmjopen-2018-023560
Open access
 25. Grant JS, Elliott TR, Giger JN, et al. Social problem-solving 
abilities, social support, and adjustment among family caregivers of 
individuals with a stroke. Rehabil Psychol 2001;46:44–57.
 26. Kimbarow ML. Integrating life participation approaches to 
aphasia treatment with adult learning theory. Top Lang Disord 
2007;27:318–23.
 27. Chapey R. Life participation approach to aphasia: A statement of 
values for the future, in Language intervention strategies in aphasia 
and related neurogenic communication disorders. Philadelphia: 
Lippincott Williams & Wilkins, 2008:279–89.
 28. Chapey R, Duchan JF, Elman RJ, et al. Life participation approach to 
aphasia: a statement of values for the future. ASHA Lead 2000;5:4–6.
 29. Hoffmann T, McKenna K, Worrall L, et al. Randomised trial of a 
computer-generated tailored written education package for patients 
following stroke. Age Ageing 2007;36:280–6.
 30. Eames S, Hoffmann T, Worrall L, et al. Randomised controlled trial 
of an education and support package for stroke patients and their 
carers. BMJ Open 2013;3:e002538.
 31. Knowles MS, Holton EF, Swanson RA. Andragogy in practice: 
expanding the usefulness of the andragogical model. The adult 
learner. 6th edn. Amsterdam: Elsevier/Butterworth Heinemann, 2005.
 32. Sharma M, Romas JA. Theoretical foundations of health education 
and health promotion. Sudbury: Jones and Bartlett Publishers, 2008.
 33. Sullivan KA, White KM, Young RM, et al. Predicting behaviour to 
reduce stroke risk in at-risk populations: the role of beliefs. Int J Ther 
Rehabil 2009;16:488–96.
 34. Rose T, Worrall L, McKenna K. The effectiveness of aphasia‐friendly 
principles for printed health education materials for people with 
aphasia following stroke. Aphasiology 2003;17:947–63.
 35. Kagan A. Supported conversation for adults with aphasia: methods 
and resources for training conversation partners. Aphasiology 
1998;12:816–30.
 36. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a 
practical guide. Clin Rehabil 2009;23:362–70.
 37. Ryan B, Hudson K, Worrall L, et al. The aphasia action, success, and 
knowledge programme: results from an australian phase i trial of a 
speech-pathology-led intervention for people with aphasia early post 
stroke. Brain Impairment 2017;18:284–98.
 38. Rose TA, Worrall LE, Hickson LM, et al. Guiding principles for printed 
education materials: design preferences of people with aphasia. Int J 
Speech Lang Pathol 2012;14:11–23.
 39. Stroke Association. Accessible information guidelines: making 
information accessible for people with aphasia. London, UK: Stroke 
Association, 2012.
 40. Finch E, Cameron A, Fleming J, et al. Does communication partner 
training improve the conversation skills of speech-language 
pathology students when interacting with people with aphasia? J 
Commun Disord 2017;68:1–9.
 41. Kagan A, Black SE, Duchan FJ, et al. Training volunteers as 
conversation partners using "Supported Conversation for Adults 
with Aphasia" (SCA): a controlled trial. J Speech Lang Hear Res 
2001;44:624–38.
 o
n
 10 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023560 on 5 May 2019. Downloaded from 
